Literature DB >> 16549419

Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies.

I S J Merkies1, P I M Schmitz.   

Abstract

OBJECTIVE: To determine which widely used disability measure in Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) shows the strongest association with patients' rating scores.
METHODS: Five disability scales and the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) were assessed serially in 20 patients with newly diagnosed GBS (n = 7) or CIDP (n = 13). Also at each visit, the patient's condition was self-assessed as being worse, unchanged or better. Longitudinal regressions were carried out to determine the association between disability scales (independent variables) and SF-36 and patients' rating scores (dependent variables).
RESULTS: Higher associations with the SF-36 were found in the Overall Disability Sum Score (ODSS) than other disability measures. A higher correlation with ODSS changes was also found in the rating scores of the patients.
CONCLUSION: In addition to literature findings, higher associations were found between Inflammatory Neuropathy Cause and Treatment Group ODSS and outcome assessed from patients' perceptions in immune-related polyneuropathies than in other commonly used disability scales.

Entities:  

Mesh:

Year:  2006        PMID: 16549419      PMCID: PMC2077640          DOI: 10.1136/jnnp.2005.076174

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

Review 1.  Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force.

Authors: 
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

2.  Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome.

Authors:  R P Kleyweg; F G van der Meché; P I Schmitz
Journal:  Muscle Nerve       Date:  1991-11       Impact factor: 3.217

Review 3.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

4.  Evaluating neurological outcome measures: the bare essentials.

Authors:  J C Hobart; D L Lamping; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

5.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

6.  Appreciating the consequences of disease: the international classification of impairments, disabilities, and handicaps.

Authors:  P H Wood
Journal:  WHO Chron       Date:  1980-10

7.  Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  R Hughes; S Bensa; H Willison; P Van den Bergh; G Comi; I Illa; E Nobile-Orazio; P van Doorn; M Dalakas; M Bojar; A Swan
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

8.  Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies.

Authors:  I S J Merkies; P I M Schmitz; F G A van der Meché; J P A Samijn; P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

9.  Quality of life complements traditional outcome measures in immune-mediated polyneuropathies.

Authors:  I S J Merkies; P I M Schmitz; F G A van der Meché; J P A Samijn; P A van Doorn
Journal:  Neurology       Date:  2002-07-09       Impact factor: 9.910

10.  Comparison between impairment and disability scales in immune-mediated polyneuropathies.

Authors:  Ingemar S J Merkies; Paul I M Schmitz; Frans G A Van Der Meché; Pieter A Van Doorn
Journal:  Muscle Nerve       Date:  2003-07       Impact factor: 3.217

  10 in total
  13 in total

Review 1.  Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.

Authors:  Lotte Vlam; W-Ludo van der Pol; Elisabeth A Cats; Dirk C Straver; Sanneke Piepers; Hessel Franssen; Leonard H van den Berg
Journal:  Nat Rev Neurol       Date:  2011-11-22       Impact factor: 42.937

2.  Defining disability: development and validation of a mobility-Disability Severity Index (mDSI) in Charcot-Marie-tooth disease.

Authors:  Sindhu Ramchandren; Michael Shy; Eva Feldman; Ruth Carlos; Carly Siskind
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-25       Impact factor: 10.154

3.  Polyneuropathy dysfunction scores.

Authors:  P J Dyck; P C O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05-18       Impact factor: 10.154

4.  A randomized trial of diagnostic ultrasound to improve outcomes in focal neuropathies.

Authors:  Michael S Cartwright; Leah P Griffin; Hugh Dowlen; Jessica M Bargoil; James B Caress; Zhongyu J Li; Anthony J Defranzo; Ethan R Wiesler; Christopher J Tuohy; Nikhil Balakrishnan; Joseph A Molnar; Vanessa Baute; L Andrew Koman; Gary G Poehling; Francis O Walker
Journal:  Muscle Nerve       Date:  2015-09-10       Impact factor: 3.217

5.  Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin.

Authors:  P Alberti; E Rossi; D R Cornblath; I S J Merkies; T J Postma; B Frigeni; J Bruna; R Velasco; A A Argyriou; H P Kalofonos; D Psimaras; D Ricard; A Pace; E Galiè; C Briani; C Dalla Torre; C G Faber; R I Lalisang; W Boogerd; D Brandsma; S Koeppen; J Hense; D Storey; S Kerrigan; A Schenone; S Fabbri; M G Valsecchi; G Cavaletti
Journal:  Ann Oncol       Date:  2013-11-19       Impact factor: 32.976

6.  Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  S Buttini; G Cappellano; P Ripellino; C Briani; D Cocito; M Osio; R Cantello; U Dianzani; C Comi
Journal:  Genes Immun       Date:  2014-10-30       Impact factor: 2.676

Review 7.  Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.

Authors:  Richard J Bright; Jenny Wilkinson; Brendon J Coventry
Journal:  BMC Neurol       Date:  2014-02-07       Impact factor: 2.474

8.  Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy.

Authors:  Angelo Maurizio Clerici; Eduardo Nobile-Orazio; Marco Mauri; Federico Sergio Squellati; Giorgio Giovanni Bono
Journal:  BMC Neurol       Date:  2017-07-01       Impact factor: 2.474

9.  The Diagnostic Utility of Determining Anti-GM1: GalC Complex Antibodies in Multifocal Motor Neuropathy: A Validation Study.

Authors:  Francesc Galban-Horcajo; Lotte Vlam; Emilien Delmont; Susan K Halstead; Leonard van den Berg; W-Ludo van der Pol; Hugh J Willison
Journal:  J Neuromuscul Dis       Date:  2015-06-04

Review 10.  Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations.

Authors:  Paolo Ripellino; Thomas Fleetwood; Roberto Cantello; Cristoforo Comi
Journal:  Autoimmune Dis       Date:  2014-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.